London: The AstraZeneca-Oxford vaccine will be tested on children in the first test by a major manufacturer on young people, University of Oxford has confirmed.

Published 6 years ago on Feb 15th 2021, 3:12 am
By Web Desk
The trial will test safety of the vaccine as well as immune system response generated by it in children aged between 6 and 17 years.
300 children will be enrolled in the trial which will take place in London, Southampton and Bristol. The trial will begin by February end, the university said in a statement.
Coronavirus has relatively been less harmful in children with milder cases as compared to adults and less contagion potential, although the jury is still out on that aspect of the virus.

COAS Munir reaffirms commitment to stronger ties with Lebanon
- 2 days ago

Why Apple’s next computer should be for the smart home
- 5 hours ago

Pakistan, Indonesia vow to strengthen defence cooperation
- 2 days ago

'Widow's Bay' scores big and 'The Pitt' wins again at TV's Emmy Awards
- 18 hours ago
Oil rises above $108 as attacks, pipeline outage deepen Saudi supply concerns
- 19 hours ago

OpenAI’s rogue AI tried to hack another company in May
- a day ago

The hidden $350 surcharge on American households
- a day ago

What an AI “slowdown” could look like
- 3 hours ago

Waymo pulls over, calls cops on riders with a ghost gun
- 5 hours ago

Yemen conflict displaces over 100,000 people, UN says
- 13 hours ago

Ex-Google DeepMind researcher adds to warnings that AI could 'kill all humans'
- 19 hours ago

Schools are catching on to Big Tech’s playbook
- 5 hours ago
You May Like
Trending

.jpg&w=3840&q=75)
